Closed
2 CPD Points
Long Acting Injectable, Cabotegravir (CAB-LA) Overview
Start date
14-10-2025
End date
14-10-2025
Time
04:45 PM
Location
Zoom
Cost
0
CPD points
2
About this activity
Cabotegravir (CAB-LA) is a long-acting injectable antiretroviral used for HIV prevention. Administered every two months, it provides an effective alternative to daily oral PrEP. CAB-LA improves adherence, reduces new HIV infections, and supports broader prevention efforts, especially among high-risk populations.